Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06468878 · ClinicalTrials.gov registry record · NA
Virtual Reality Intervention for Fear of Heights
A NA study of Acrophobia, sponsored by Boston University Charles River Campus.
- Recruiting
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT06468878: Recruiting NA study of Acrophobia, sponsored by Boston University Charles River Campus.
NCT06468878 is a NA study of Acrophobia that is actively recruiting participants, run by Boston University Charles River Campus. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06468878, a NA study of Acrophobia, is actively recruiting participants, sponsored by Boston University Charles River Campus.
- RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Exposure-based cognitive behavior therapy is an efficacious treatment for acrophobia (fear of heights) and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate the effects of liked, non-lyrical background music on the efficacy of a brief VR exposure intervention.
Primary Outcome
Assessed using the Acrophobia Questionnaire (AQ) Anxiety Subscale
Conditions Studied
Interventions
- BEHAVIORAL Exposure Intervention Plus Music Induction
- BEHAVIORAL Exposure Intervention With No Music Induction
Study Locations (1)
Massachusetts
- Boston University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2024-07-08 |
| Est. Completion | 2025-05 |
| Phase | NA |
What NCT06468878 shows while recruiting
NCT06468878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Acrophobia appearing as the primary indexed condition, and to 2 interventions - of which Exposure Intervention Plus Music Induction is the first listed.
NCT06468878 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06468878 about?
NCT06468878 is a clinical study titled "Virtual Reality Intervention for Fear of Heights". Exposure-based cognitive behavior therapy is an efficacious treatment for acrophobia (fear of heights) and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate the effects of liked, non-lyrical background music on the efficacy of a brief VR ...
What is the current status of trial NCT06468878?
This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2024-07-08. Estimated completion is 2025-05.
What conditions does trial NCT06468878 study?
This clinical trial studies the following conditions: Acrophobia.
What interventions are being tested in trial NCT06468878?
The interventions under investigation include: Exposure Intervention Plus Music Induction (BEHAVIORAL), Exposure Intervention With No Music Induction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06468878?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06468878 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06468878's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI